OxTalks is Changing
Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Restoring the balance with Regulatory T Cell Therapies
Quell Therapeutics is a London based, private biopharmaceutical company. Their vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.
Date:
18 January 2024, 12:00
Venue:
Seminar room
Speaker:
Luke Devey (Chief Medical Officer)
Organising department:
Department of Paediatrics
Organiser:
Sheena Lee (MSD Business Partnerships Office)
Booking required?:
Not required
Booking url:
https://forms.office.com/e/suZ1J5CiU1
Cost:
None
Audience:
Members of the University only
Editor:
Laura Borg